Announcement on Convening the 2025 and 2026 First Quarter Performance Briefing Meeting
Securities code: 600812 Securities abbreviation: North China Pharmaceutical Number: Lin 2026-021
North China Pharmaceutical Co., Ltd.
Announcement on Convening the 2025 and 2026 First Quarter Results Briefing
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Meeting time: May 15, 2026 (Friday) 15:00-16:00
Meeting location: Value Online (www.ir-online.cn)
Meeting method: Internet interactive method
Investors can visit the website https://eseb.cn/1xEVGF0z2da before 16:00 on Thursday, May 14, 2026, or use WeChat to scan the mini program code below to ask questions before the meeting. The company will answer questions of common concern to investors through this performance briefing meeting within the scope of information disclosure.
North China Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") has released the company's 2025 annual report and 2026 first quarter report on April 18, 2026 and April 25, 2026. In order to facilitate investors to have a more comprehensive and in-depth understanding of the company's operating results and financial status in 2025 and the first quarter of 2026, the company plans to hold the 2025 and first quarter 2026 performance briefing at "Value Online" (www.ir-online.cn) from 15:00-16:00 on May 15, 2026 (Friday) to communicate on issues of common concern to investors.
1. Type of briefing session
This investor briefing will be held in an online interactive format. The company will interact and communicate with investors on the specific operating results and financial indicators in 2025 and the first quarter of 2026, and answer questions of common concern to investors within the scope permitted by information disclosure.
2. Time and place of the briefing meeting
(1) Meeting time: May 15, 2026 (Friday) 15:00-16:00
(2) Meeting location: Value Online (www.ir-online.cn)
(3) Meeting method: Internet interactive method
3. Participants
Chairman: Mr. Wang Lixin
Chief Accountant, Financial Manager, Secretary of the Board of Directors: Mr. Xiao Zhiguang
Independent Director: Mr. Chai Zhenguo
(If there are special circumstances, the number of participants will be adjusted)
4. How to participate as an investor
(1) Investors can enter and participate in interactive communication at 15:00-16:00 on May 15, 2026 (Friday) through the website https://eseb.cn/1xEVGF0z2da or by using WeChat to scan the mini program code below.
(2) Investors can ask questions before the meeting before 16:00 on May 14, 2026 (Thursday). The company will answer questions of common concern to investors through this performance briefing within the scope permitted by information disclosure.
5. Contact person and consultation method
Contact person: Luo Jianan
Contact number: 0311-85992039
Email: [email protected]
6. Other matters
After the performance briefing is held, investors can check the status and main content of the performance briefing through Value Online (www.ir-online.cn) or the Yidong app.
Announcement is hereby made.
North China Pharmaceutical Co., Ltd.
May 7, 2026